These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 7184436

  • 1. [Combination therapy of large amount of carboquone and OK-432 for unresectable lung cancer].
    Nakarai I, Honda T, Jinnai S, Kita T, Shinoda A.
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1006-11. PubMed ID: 7184436
    [Abstract] [Full Text] [Related]

  • 2. [Combination therapy of high-dose carboquone and OK-432 in unresectable non-small cell lung cancer].
    Nakarai I, Ueno T, Hayashi A, Shinoda A.
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3508-12. PubMed ID: 3024582
    [Abstract] [Full Text] [Related]

  • 3. [Combined chemotherapy of ovarian cancer with special reference to carboquone].
    Sugimori H, Kidera Y, Matsuyama T.
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):66-71. PubMed ID: 6307172
    [Abstract] [Full Text] [Related]

  • 4. [Combination chemotherapy with peplomycin and carboquone (esquinon) for squamous cell carcinoma of the lung].
    Negoro S, Fukuoka M, Takada M, Tamai S, Sakai N, Matsui K.
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):522-8. PubMed ID: 6191699
    [Abstract] [Full Text] [Related]

  • 5. [Effect of intravenous treatment with OK-432 on the bone marrow in patients with lung cancer].
    Fujii M, Ishikawa M, Toki H.
    Gan No Rinsho; 1984 Mar; 30(3):230-2. PubMed ID: 6325756
    [Abstract] [Full Text] [Related]

  • 6. [Effect of combined use of radiation and twice intratumor administration of OK-432 at one week intervals against a murine fibrosarcoma (NFSA)].
    Mukai M, Ando K, Koike S.
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):631-5. PubMed ID: 3355184
    [Abstract] [Full Text] [Related]

  • 7. [MQF-OK therapy in advanced terminal stomach cancer--with special reference to a comparison with MFC therapy].
    Sakata Y, Yoshida Y, Komatsu Y, Sugawara K, Nishimura S, Kikuchi K.
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):109-15. PubMed ID: 6820875
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Effect of intra-thoracic administration of an immune modulator (OK-432) with anti-cancer drugs (ADR and MMC)].
    Hattori H, Mikuriya S, Mamiya T, Hatano K, Shiina T, Yamada T.
    Gan No Rinsho; 1988 Jun; 34(7):851-6. PubMed ID: 3135423
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Evaluation of various administration routes of the streptococcal preparation, OK-432, with regard to their in vivo effect by lymphocytes proliferation assay].
    Kimura Y, Toki H, Okabe K, Fujii M, Tamai M.
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):95-100. PubMed ID: 3942400
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Combination chemotherapy of mitomycin-C, carboquone, 5-fluorouracil and OK-432 for inoperable gastric cancer (author's transl)].
    Sakata Y, Sugawara K, Komatsu Y, Yoshida Y, Nishimura S, Kikuchi K.
    Nihon Gan Chiryo Gakkai Shi; 1979 Oct 20; 14(6):978-87. PubMed ID: 541534
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [A case of relapsed pulmonary carcinoma showing an interesting chemotherapeutic course].
    Koga T, Nakarai I, Rikitake H, Shinoda A.
    Gan To Kagaku Ryoho; 1987 Dec 20; 14(12):3355-8. PubMed ID: 3688895
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.